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Abstract
Introduction. The determination of ethyl glucuronide (EtG), a stable and sensitive 
marker that is specific to alcohol intake, finds many applications both in the forensic 
toxicology and clinical fields.
Aim. The aim of the study is to examine the possibility of using a cadaveric biological 
matrix, vitreous humor (VH), to determine EtG as a marker of recent ethanol use.
Methods. The blood, taken from the femoral vein, and the VH were obtained from 63 
autopsy cases. Analysis of the EtG was performed using an LC/MS/MS system. Analyses 
of the ethanol and putrefaction biomarkers, such as acetaldehyde and n-propanol, were 
performed using the HS-GC/FID technique in both the matrices.
Results. In 17 cases, both ethanol and EtG were absent in both matrices.Nineteen cases 
presented ethanol in blood from 0.05 to 0.30 g/L, EtG-Blood concentration from 0.02 
to 3.27 mg/L, and EtG-VH concentration from 0.01 mg/L to 2.88 mg/L. Thirteen cases 
presented ethanol in blood > 0.05 g/L but EtG concentration in blood and VH lower 
than 0.01 mg/L, are part of these 8 samples presented acetic aldehyde and n- propanol in 
blood or VH, means identification of putrefaction indicators. Fourteen cases presented 
ethanol in blood > 0.46 and EtG concentration in blood and VH higher than 0.01 mg/L.
Conclusions. The determination of EtG in biological material is important in those 
cases where the intake of ethanol appears doubtful, as it allows us to exclude the possibil-
ity of any post-mortem formation of ethanol.
INTRODUCTION
In the western world the consumption of ethanol is 
a social and economic problem of great importance. 
According to statistics, 20-30% of the costs relating to 
health care are to be attributed to alcohol abuse [1].
In particular, in Italy the habit of consuming alcoholic 
beverages affects almost 13 500 people, aged 11 and 
over. 
If the percentage of consumers, according to their 
consumption habits, for example with meals or between 
meals, is considered there are marked differences in 
gender. Almost one in two men also consumes alcohol 
between meals (46.20%), whilst women with the same 
habit are approximately one in four (26.8%). The differ-
ences in gender are almost negligible in the age group 
ranging from 18-24 years [2].
The identification and quantification of biomarker, 
specific for the consumption and/or abuse of alcohol, 
is of relevance for forensic purposes since it offers the 
possibility of distinguishing between the intake of alco-
hol in matrices such as blood and serum (in the short 
term), urine (in the medium term) and hair and meco-
nium (in the long term) [3-5]. 
Ethyl glucuronide (EtG), being a direct metabolite of 
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ethanol, could be used as highly specific direct marker 
for assessing the intake of alcohol in the medium term. 
It was identified for the first time in 1952 by Kamil, in 
the urine of rabbits, as triacetyl-methyl-ester [6].
EtG is a non-volatile polar, relatively stable molecule. 
It derives from the conjugation of ethanol with gluc-
uronic acid activated via mediation of UDP-glucuronyl 
transferase (UGT) in the endoplasmic reticulum of the 
hepatocytes. 
Only 0.02-0.06% of the ethanol ingested is trans-
formed into EtG. 
The kinetics of EtG has been examined. This study 
showed that the comsumption of a quantity of ethanol, 
capable of determining a level of alcohol of 0.50 g/Kg, is 
sufficient to result in the formation of EtG, that can be 
detected in the blood after just four hours from inges-
tion, and remains for up to 14 hours [7].
In the field of toxicology and forensics, EtG is of 
particular interest due to its possible applications [8-
10]. 
For example, it may be used to differentiate between 
ante-mortem alcohol intake and post-mortem forma-
tion due to putrefactive processes. In postmortem etha-
nol analysis, the most commonly used sample matrix 
is whole blood.  It is known that blood is susceptible 
to possible post-mortem changes. Indeed, a certain 
quantity of ethanol may be generated by post-mortem 
fermentative phenomena, initiated by several micro-
organisms, including Escherichia coli, starting from 
glucidic substrates in the blood, thus biasing analytical 
findings [11, 12]. To overcome this limitation, the use 
of an alternative/complementary matrix to the blood is 
of great relevance for forensic purposes [13].
Vitreous humor (VH), has a liquid character and re-
sists putrefaction, which make it an attractive material 
for quantitative analysis in cases where blood is not 
available or deteriorated. 
VH is less affected by these changes and should, 
therefore, provide a more reliable estimation of ante-
mortem drug concentrations [14].
AIM
The aim of the study is to examine the possibility of 
using a cadaveric biological matrix, VH, to determine 
EtG as a marker of recent alcoholic use to supplement 
blood alcohol concentration measurements [15].
The use of this alternative matrix, already successfully 
experimented in studies on the detection of ethanol, 
can allow to obtain important data on the ante-mortem 
alcohol intake [16, 17]. 
MATERIALS AND METHODS 
Reagents 
The following reagents were used for the analysis: β-d-
ethyl glucuronide and β-d ethyl glucuronide d-5 sup-
plied by Cerilliant®, both at a concentration of 100 µg/
mL and with a high degree of purity, acetonitrile ultra 
resi-analyzed® (J.T.Baker®), methanol (Sigma-Aldrich®), 
water (J.T.Baker®), formic acid 5M (Agilent Technolo-
gies, Milan, Italy). Tert-butanol (Sigma-Aldrich®). The 
aqueous solution was filtered on 0.45 µm PTFE filters 
(SUN.Sri, Duluth, GA,USA). 
Samples
For this study samples were analysed from 63 au-
topsies (53 male subjects and 10 female) performed at 
the Institute of Forensic Medicine at the University of 
Brescia, from 2003-2011. In all cases, blood was taken 
from the femoral vein and VH from one or both eye-
balls. Blood and VH were collected in medico-legal 
autopsies with a syringe and a needle, within 48 hours 
after the discovery of the deceased. 
The “blank” samples for preparing the standard cali-
bration curves on blood were supplied by the Spedali 
Civili di Brescia Hospital’s transfusion service and test-
ed negative for ethanol and EtG. 
The “blank” samples for preparing the standard cali-
bration curves on VH were obtained from deceased pa-
tients that underwent to legal autopsy and tested nega-
tive for ethanol and EtG.
Following collection, blood specimen preserved with 
potassium floride, and VH samples, were stored at 
-20 °C until analysis.
Analytical method – Ethanol, acetaldehyde, 
n-propanol analysis
Blood and VH samples were subjected to quantitative 
determination of ethanol and identification of putrefac-
tion indicators such as acetaldehyde and n-propanol us-
ing headspace method [18-22].
Analyses were performed using Agilent Technologies® 
6850 Series CG System coupled with a flame ioniza-
tion detector (FID) equipped with a Agilent J &W DB-
LC1 capillary column (30 m x 0.32 mm i.d., 1.8 µm film 
thickness).
The injection was performed in split ratio mode 20:1. 
Before injection samples were heated at 60 °C for 20 
minutes. 
The analytes were identified by comparison of the re-
tention times with those of standard solutions. A satis-
factory separation required 6 min.
Ethanol concentration was performed using tert-bu-
tanol as the internal standard in linear calibration with 
0.05-0.10-0.20-0.50-1.00-2.00-5.00 g/L aqueous etha-
nol solution. The lower limit of quantification (LLOQ) 
was 0.05g/L [23, 24].
Statistical issues
Dosages of ethanol blood, ethanol-VH, EtG-Blood, 
EtG-VH, were means of 63 samples tested in duplicate. 
The comparison of ethanol blood and EtG-VH con-
centration and comparison of ratio ethanol blood/EtG-
Blood and ethanol blood/EtG-VH when applicable, 
Scatter diagram regression were used (P < 0.05 was 
considered as statistically significant).
Analytical method – Ethyl glucuronide analysis
An HPLC 1260 System equipped with an infinity 
system model 1260 injector and paired with an Agilent 
Technologies 6460 Triple Quad LC/MS triple quadru-
pole mass spectrometer was used for the quantitative 
dosage of EtG. 
Chromatographic separation of EtG and internal 
standard Ethyl glucuronide – d5 was achieved using 
INERTSIL ODS-3 100 × 3 mm, 3 μm coupled with a 
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security guard column. The flow rate was 0.3 mL/min 
with mobile phase of 0.01% Formic Acid in water (A) 
and acetonitrile (B). The column was equilibrate with 
2% B for 3 min, A linear gradient to 95% B was applied 
over 12 min. The total run time was 15 min per sample 
[25-27].
An Agilent (Waldbronn, Germany) 6460 triple quad-
rupole mass spectrometer equipped with a Jet Stream-
Electrospray ion source operating in negative-ion mode 
was used as detection system. The optimal source pa-
rameter were: source temperature: 300 °C, drying gas 
flow: 12 L/min, drying gas temp: 350 °C, nebulizer 
pressure: 40 psi, capillary voltage: 3.500 V and nozzle 
voltage: 0V.
The transitions were optimized and were selected 
as follows: m/z 221.1, 85.3 and 221.1, 75.2 for Ethyl 
glucuronide and 226.1, 85.1 and 226.1, 75.0 for Ethyl 
glucuronide-d5 (EtG-D5).
For all transition, dwell time was set at 20 ms. 
EtG VALIDATION FOR BLOOD AND VH 
SAMPLES
Linearity of calibration
To validate the quantitative analytical method for 
EtG in the blood and VH samples, 4 calibration curves 
were prepared for both matrices by adding 80 µL of 
blood/VH “blank” to 20 µL of pure EtG standard in a 
methanol solution at known and scalar concentrations, 
to obtain the following calibration points: 0.00-0.01-
0.02-0.05-0.1-0.2-0.5-1.00 mg/L.
20 µL of deuterated internal standard (EtG-d5) 
was added to each calibration point, at concentration 
of 0.50 ng/µL (0.10 mg/L), freshly prepared from the 
stock solution before each analysis and stored at -20 °C. 
The blood and VH samples were deproteinized by 
adding 250 µl of acetonitrile and 250 µL of methanol, 
respectively, mixed and centrifuged at 13000 rpm for 10 
minutes. The supernatants were transferred to a coni-
cal test tube and were dried under a stream of nitro-
gen [15]. The dried extracts were then reconstituted in 
500 µL of ultra-filtered water containing formic acid at 
0.01%, transferred to vials with screw tops and analysed 
using LC/ESI-MS/MS. 
The linearity of the two methods was verified by pre-
paring 4 calibration curves for each matrix; the results 
obtained are represented by regression lines with the 
least-squares method.
Selectivity
Selectivity was tested by analysing 10 samples of 
“blank blood” and 10 samples of “blank VH”, supple-
mented with the internal standard (EtG-D5) at a con-
centration of 0.1 mg/L, to verify the absence of interfer-
ing substances that could co-elute with the interested 
analytes.
Precision and accuracy
To evaluate the intraday and inter-day precision of 
this method, 6 replicates of “blank blood” and “blank 
VH” samples, spiked with different concentration of 
EtG standard (0.01 mg/L, 0.05 mg/L, 0.10 mg/L e 0.20 
mg/L) were analysed on 4 different days.
The intraday and inter-day precision was estimated 
by calculating the coefficient of variation percentage 
(C.V.%).
The accuracy for both matrices was calculated from 
the percentage of deviation of the mean of the results 
from the corresponding nominal value. 
Long term stability
The stability of the analytes was assessed using real 
samples of blood and VH that resulted positive for EtG 
upon first analysis. These were stored in the dark at -20 
°C and analysed again after 15 days and 30 days of stor-
age.
Matrix effect
The matrix effect was determined by comparing the 
responses obtained from the analysis of 6 replicates 
of aliquots of blank matrix of blood and VH, fortified 
at a concentration of 0.05-0.10-0.20 mg/L, with those 
obtained from the analysis of similar aliquots of water, 
fortified at the same concentrations. 
Examined samples 
To evaluate the concentration of EtG in the blood 
and VH samples, 100 µL of each samples, brought to 
room temperature, were spiked with 20 µL (0.10 mg/L) 
of deuterated internal standard (EtG-d5), freshly pre-
pared from the stock solution and stored at -20 °C until 
use.
The blood and VH samples were deproteinized by 
adding 250 µL of acetonitrile and 250 µL of methanol 
respectively mixed and centrifuged at 13000 rpm for 10 
minutes. The supernatants, once transferred to a coni-
cal test tube, were dried under a stream of nitrogen. 
The residues were then reconstituted with 500 µL 
of ultra-filtered water containing formic acid at 0.01%, 
transferred to vials with screw tops and analysed using 
LC/ESI-MS/MS.
RESULTS
To achieve the aim of the present study, that is the 
possible use of VH sample as a marker of recent alco-
holic intake, it was necessary to verify that the applied 
LC/ ESI-MS/MS method could be specific, sensitive, 
precise and accurate for determining EtG in the bio-
logical samples.
First, the linearity response for blood and VH sam-
ples was studied. The method showed a linear response 
between 0.00 and 1.00 mg/L for both matrices (R2 
blood = 0.998, R2 VH = 0.995) (Table 1).
The selectivity of the developed method was evalu-
ated analyzing blank samples. The absence of interfer-
ing substance that could co-elute with the interested 
analytes and thus could bias the quantification results, 
confirmed that the method was highly specific for both 
matrices. 
Then the EtG stability in both matrices was evaluated 
on 10 positive blood and VH samples over a period of 4 
weeks. Samples were kept in the dark at -20 °C and sub-
jected to analysis after 30 days. The average variation 
detected between the first (day 1) and second analysis 
(day 30) was of 8%.
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The sensitivity of the tests was confirmed by assessment 
of the LLOQ (S/N ratio of 10) and of the LOD (S/N ratio 
of 3) for EtG both in blood and in VH (LOQ blood and 
VH 0.01mg/L, LOD blood and VH 0.005 mg/L.) 
Evaluation of the precision of the analytical method 
allowed us to verify that the coefficient of variation, cal-
culated for each concentration analysed, was less than 
12% of all the concentrations examined. 
The accuracy, determined on the same concentra-
tions of the analyte used to estimate precision, on the 
basis of the data obtained provided a percentage error 
within ± 15% (Table 2). 
To investigate possible EtG matrix effects, including 
ionization or suppression, the signal responses from 
standards prepared in water and those prepared in ma-
trix extract (blood end VH) were compared.
The concentration was higher in blood. The matrix 
effect at a concentration of 0.10 mg/L, proved to be less 
than 15% for both matrices (Table 3).
After validation of the analytical method, 63 autopsy 
samples of blood and VH were subjected to analysis to 
detect EtG; the results were subsequently compared 
with the quantities of ethanol in both matrices to obtain 
further information on the intake of alcohol.
Furthermore, two important putrefaction markers 
were evaluated in the cadaver blood, acetic aldehyde 
and n-propanol, produced by post-mortem fermenta-
tion processes, with the aim of discovering whether the 
source of the ethanol in the blood was of a putrefactive 
nature. Table 4 shows the analytical results of the 63 
autopsy cases that were examined.
Seventeen cases (1, 2, 4, 6, 22, 23, 24, 32, 37, 39, 44, 
46, 48, 51, 54, 57, 60) on 63 presented ethanol in blood 
= 0.00 g/L or ≤ 0.05 g/L (LLOQ), blood and and EtG-
VH concentration were ≤ LLOQ (0,01 mg/L) ± 15%. 
Nineteen cases presented ethanol in blood from 0.05 
to 0.30 g/L, EtG-Blood concentration from 0.02 to 3.27 
mg/L, median 0.18 mg/L and mean 0.83 mg/L. The same 
Table 1
Blood and vitreous humor calibration results
Blood Vitreous humor
Date Slope Intercept R2 Slope Intercept R2
70711 0.746 0.035 0.999 0.808 0.201 0.989
190711 0.703 0.018 0.999 0.710 0.366 1.000
030811 0.746 0.012 0.996 0.702 0.239 0.999
260911 0.783 0.037 0.998 0.747 0.316 0.993
Average 0.745 0.025 0.998 0.742 0.281 0.995
DS 0.033 0.012 0.001 0.048 0.074 0.005
Table 2 
Accuracy and precision data. Evaluation in blood and vitreous humor
Matrix Nominal conc. 
(mg/L)
Mean calculate 
(mg/L)
Accuracy (bias% 
n = 24)
Intraday precision 
(CV% n = 6)
Interday precision 
(CV% n = 24)
Blood 0.01 0.012 22.00 14.60 15.25
0.05 0.059 17.30 7.90 8.72
0.10 0.115 14.50 6.00 7.62
0.20 0.219 9.30 6.30 5.99
Vitreous humor 0.01 0.011 15.00 14.30 15.13
0.05 0.058 16.00 6.40 6.33
0.10 0.109 9.00 5.20 6.11
0.20 0.204 2.00 3.00 4.23
Table 3 
EtG matrix effect: mean concentration at 0.050- 0.100 -0.200 
mg/L for aqueous standards, blood and vitreous humor
EtG matrix effect Mean 
concentration
mg/L (n = 6)
Accuracy %
(n = 6)
0.050 mg/L  Prepared standard
Aqueous 0.048 - 4.00
Blood 0.058 16.00
Vitreous humor 0.057 14.00
0.100 mg/L prepared standard 
Aqueous 0.105 5.00
Blood 0.112 12.00
Vitreous humor 0.108 8.00
0.200 mg/L prepared standard 
Aqueous 0.203 1.50
Blood 0.218 9.00
Vitreous humor 0.206 3.00
Ethyl glucuronidE in postmortEm spEcimEns
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
23
Table 4 
Samples results: ethanol and EtG concentration in blood and vitreous humor (VH); qualitative results of n-propanol and acetic 
aldehyde in blood and vitreous humor (VH)
SAMPLE Ethanol (g/L) EtG (mg/L) n-propanol Acetic aldehyde Sex Cause of death
Blood v.h. Blood v.h. Blood v.h. Blood v.h.
1 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m cardiac death
2 0.00 0.00 0.01 0.00 Assent Assent Assent Assent m drug intoxication
3 0.93 0.81 2.59 0.42 Assent Assent Assent Assent m haemorrhage
4 0.00 0.00 0,00 0.00 Assent Assent Assent Assent m polytrauma
5 0.10 0.06 0.07 0.02 Assent Assent Assent Assent m cardiac death
6 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m cardiac death
7 0.20 0.05 0.75 0.49 Assent Assent Assent Assent m polytrauma
8 0.59 0.34 0.45 0.22 Assent Assent Assent Assent m suffucation
9 0.27 0.18 0.00 0.00 Assent Assent Present Present m coronary heart disease
10 1.45 0.00 3.51 1.60 Assent Assent Assent Assent m drug intoxication
11 0.30 0.12 3.24 1.67 Assent Assent Assent Assent m drug intoxication
12 1.86 0.00 0.01 0.04 Assent Assent Assent Assent m thorax trauma
13 0.18 0.10 2.27 2.13 Assent Assent Assent Assent m cardiac death
14 1.82 0.00 2.22 2.54 Assent Assent Assent Assent f cardiac death
15 1.25 0.00 0.00 0.00 Assent Assent Present Assent m drug intoxication
16 0.28 0.16 0.02 0.01 Present Present Assent Present f cerebral trauma
17 0.05 0.05 0.68 0.28 Assent Assent Assent Assent m drug intoxication
18 0.05 0.05 0.14 0.10 Assent Assent Assent Assent m haemorrhage
19 0.05 0.05 0.12 0.01 Assent Assent Assent Assent m suffucation
20 0.49 0.00 0.00 0.00 Assent Assent Present Assent m cardiac death
21 0.31 0.10 0.01 0.12 Assent Assent Assent Assent m thrombosis
22 0.00 0.00 0.01 0.01 Assent Assent Assent Assent m drug intoxication
23 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m cardiac death
24 0.00 0.00 0.01 0.01 Assent Assent Assent Assent m drug intoxication
25 1.71 0.32 0.61 0.30 Assent Assent Assent Assent m coronary heart disease
26 0.10 0.00 0.00 0.00 Assent Assent Assent Assent m drug intoxication
27 0.20 0.20 0.25 0.12 Assent Assent Assent Assent m drug intoxication
28 0.56 0.00 0.01 0.00 Assent Assent Present Present f cerebral trauma
29 0.12 0.00 0.07 0.04 Assent Assent Assent Assent m drug intoxication
30 0.22 0.00 0.00 0.01 Assent Assent Assent Assent m polytrauma
31 0.39 0.20 0.00 0.02 Assent Assent Present Present f suffucation
32 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m thrombosis
33 0.15 0.00 0.00 0.00 Assent Assent Assent Assent m drug intoxication
34 0.37 0.05 0.00 0.00 Assent Assent Present Assent m drug intoxication
35 0.55 0.29 0.07 0.02 Assent Assent Assent Assent f cerebral trauma
36 1.99 0.23 18.3 12.53 Assent Assent Assent Assent m drug intoxication
37 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m suffucation
38 0.20 0.11 3.27 0.18 Assent Assent Assent Assent m polytrauma
39 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m coronary heart disease
40 0.20 0.05 2.12 2.67 Assent Assent Assent Assent m drug intoxication
41 0.20 0.00 0.00 0.00 Assent Assent Assent Assent m cardiac death
42 0.55 0.57 2.73 0.50 Assent Assent Assent Assent m drug intoxication
43 2.32 0.32 20.05 5.86 Assent Assent Assent Assent m drug intoxication
(continues)
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samples presented EtG-VH concentration from 0.01 
mg/L to 2.88 mg/L, median 0.22 mg/L, and mean 0.65 
mg/L, while in the same samples acetic aldehyde and n- 
propanol were absent, indicating that the prior intake of 
alcoholic beverages is likely (cases: 5, 7, 11, 13, 16, 17, 
18, 19, 27, 29, 38, 40, 47, 49, 53, 55, 56, 61, 62).
Thirteen cases presented ethanol in blood > 0.05 g/L 
but EtG concentration in blood or/and VH lower than 
0.01 mg/L (cases: 9, 15, 20, 21, 26, 28, 30, 31, 33, 34, 
41, 52, 59).
Twelve cases presented ethanol in blood > 0.06 g/L 
but ethanol VH concentration 0.00 g/L (cases: 10, 12, 
14, 5, 20, 26, 8, 29, 30, 33, 42, 59). In 9, 15, 16, 20, 28, 
31, 34 and 52 samples acetic aldehyde and n- propanol 
were present in blood or VH, means identification of 
putrefaction indicators (Table 5).
Fourteen cases presented ethanol in blood > 0.46 and 
EtG concentration in blood and VH higher than 0.01 
mg/L (cases: 3, 8, 10, 12, 14, 25, 35, 36, 42, 43, 45, 50, 
58, 63). 
Figure 1 shows correlation between ethanol in blood 
and EtG-VH in 63 cases. 
The correlation coefficient (r) was 0.585 with P < 0.0001 
and 95% confidence interval for r = 0.395 to 0.727.
Figure 2 shows the correlation between ratio ethanol 
in blood /EtG-Blood and ethanol in blood /EtG-VH in 
34 comparable samples. 
The correlation coefficient (r) was 0.798 with P < 0.0001 
and 95% confidence interval for r = 0.629 to 0.895.
DISCUSSION  
This allows us to assume a probable neo-formation 
of ethanol from a cadaveric source, supported by the 
presence of acetaldehyde or n-propanol as a indicators 
of fermentation (samples 9, 15, 16, 20, 28, 31, 34 and 
52).  
Samples 20 and 28 showed ethanol in blood concen-
tration were 0.49 and 0.56 respectively, but EtG blood 
concentration was ≤ LLOQ ± 15%: this fact probably 
indicates a post-mortem ethanol neo-formation.
Cases 10, 26, 30, 33, 41 and 59 were positive for 
ethanol in blood (> 0.06 g/L), but EtG in blood and 
VH concentration ≤ LLOQ ± 15%. Acetaldehyde and 
n- propanol were absent.
Cases 15, 20, 28 presented ethanol in blood of 1.25 
g/L, 0.49 g/L and 0.56 g/L respectively, but negative for 
EtG in both matrices, as well as showing the presence 
of acetaldehyde in the blood.
Analyzing the results of correlation between ethanol 
in blood and EtG-VH the data had a linear distribution 
on the graphic (Figure 1), except for the samples whit 
EtG-VH > 1.00 mg/L when we can note the dispersion. 
Figure 2 shows minor dispersion of the data.
Study of relationship between EtG-VH and EtG-
Blood showed that more than 90% of the samples fea-
ture matching. Indeed the cases 2, 28, 48 and 52 had 
EtG only in blood but not in VH. This can be explained 
by the LLOQ EtG -Blood concentration. The cases 30 
and 31 had EtG only in VH but not in blood.
(continued)
SAMPLE Ethanol (g/L) EtG (mg/L) n-propanol Acetic aldehyde Sex Cause of death
Blood v.h. Blood v.h. Blood v.h. Blood v.h.
44 0.00 0.00 0.00 0.00 Assent Assent Assent Assent f haemorrhage
45 1.56 0.32 5.03 2.99 Assent Assent Assent Assent f suffucation
46 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m polytrauma
47 0.05 0.05 0.18 0.38 Assent Assent Assent Assent m drug intoxication
48 0.00 0.00 0.01 0.00 Assent Assent Assent Assent m suffucation
49 0.15 0.10 0.06 0.02 Assent Assent Assent Assent f haemorrhage
50 0.46 0.36 11.59 4.24 Assent Assent Assent Assent f drug intoxication
51 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m drug intoxication
52 0.29 0.05 0.02 0.00 Present Assent Assent Assent m haemorrhage
53 0.10 0.31 0.43 0.50 Assent Assent Assent Assent m haemorrhage
54 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m cardiac death
55 0.05 0.05 0.92 2.88 Assent Assent Assent Assent f drug intoxication
56 0.05 0.05 1.74 0.12 Assent Assent Assent Assent m drug intoxication
57 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m drug intoxication
58 1.18 1.29 11.98 6.90 Assent Assent Assent Assent m drug intoxication
59 0.06 0.00 0.00 0.00 Assent Assent Assent Assent m haemorrhage
60 0.00 0.00 0.00 0.00 Assent Assent Assent Assent m suffucation
61 0.27 0.10 0.03 0.52 Assent Assent Assent Assent m cardiac death
62 0.09 0.05 0.16 0.06 Assent Assent Assent Assent m hanging
63 1.21 0.99 3.58 0.43 Assent Assent Assent Assent m cardiac death
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Knowing the kinetics of ethanol and its direct me-
tabolite, it is possible to assume in these cases that 
there was an intake of alcohol within three hours prior 
to death.
This could be explained by the fact, clearly expressed 
in scientific literature, that the microsomal enzyme re-
sponsible for the ethanol glucuronidation reaction exists 
as a super-family of enzymes. The polymorphic variants 
in the genes that encode UTG may have a significant 
impact on the ability of man to synthesise EtG and may 
contribute to explaining the inter-individual difference 
in the level of EtG after consuming alcohol [28]. 
CONCLUSIONS
Introduction of the determination of EtG into the 
analytical protocol of a chemical-toxicological labora-
tory is of significant interest not only on an exclusively 
clinical level (rehabilitation programs for alcoholic pa-
tients) but also, and above all, on the penal and admin-
istrative aspects of forensic-toxicological investigations. 
In fact, the identification of EtG in biological samples 
is an extremely useful analytical-diagnostic indicator in 
highlighting the prior intake of alcohol as it is a medium 
term marker of such intake.
In the interest of forensics and toxicology, in cases 
Table 5
Nineteen cases presented ethanol in blood from 0.05 to 0.30 g/L, EtG-Blood concentration from 0.02 to 3.27 mg/L and EtG-VH 
concentration from 0.01 mg/L to 2.88 mg/L, 13 cases presented ethanol in blood > 0.05 g/L but EtG concentration in blood and VH 
lower than 0.01 mg/L. Samples 9, 15, 16, 20, 28, 31, 34 and 52 acetic aldehyde and n- propanol were present in blood or VH, means 
identification of putrefaction indicators
Sample Ethanol (g/L) EtG (mg/L) n-propanol Acetic aldehyde
Blood v. h Blood v. h Blood v. h Blood v. h
5 0.10 0.06 0.07 0.02 Assent Assent Assent Assent
7 0.20 0.05 0.75 0.49 Assent Assent Assent Assent
9 0.27 0.18 0.00 0.00 Assent Assent Present Present
11 0.30 0.12 3.24 1.67 Assent Assent Assent Assent
13 0.18 0.10 2.27 2.13 Assent Assent Assent. Assent.
15 1.25 0.00 0.00 0.00 Assent Assent Present Assent
16 0.28 0.16 0.02 0.01 Present Present Assent Present
17 0.05 0.05 0.68 0.28 Assent Assent Assent Assent
18 0.05 0.05 0.14 0.10 Assent Assent Assent Assent
19 0.05 0.05 0.12 0.01 Assent Assent Assent Assent.
20 0.49 0.00 0.00 0.00 Assent Assent Present Assent
21 0.31 0.10 0.01 0.12 Assent Assent Assent Assent
26 0.10 0.00 0.00 0.00 Assent Assent Assent Assent
27 0.20 0.20 0.25 0.12 Assent Assent Assent Assent
28 0.56 0.00 0.01 0.00 Assent Assent Present Present
29 0.12 0.00 0.07 0.04 Assent Assent Assent Assent
30 0.22 0.00 0.00 0.01 Assent Assent Assent Assent
31 0.39 0.20 0.00 0.02 Assent Assent Present Present
33 0.15 0.00 0.00 0.00 Assent Assent Assent Assent
34 0.37 0.05 0.00 0.00 Assent Assent Present Assent
38 0.20 0.11 3.27 0.18 Assent Assent Assent Assent
40 0.20 0.05 2.12 2.67 Assent Assent Assent Assent
41 0.20 0.00 0.00 0.00 Assent Assent Assent Assent
47 0.05 0.05 0.18 0.38 Assent Assent Assent Assent
49 0.15 0.10 0.06 0.02 Assent Assent Assent Assent
52 0.29 0.05 0.02 0.00 Present Assent Assent Assent
53 0.10 0.31 0.43 0.50 Assent Assent Assent Assent
55 0.05 0.05 0.92 2.88 Assent Assent Assent Assent
56 0.05 0.05 1.74 0.12 Assent Assent Assent Assent
59 0.06 0.00 0.00 0.00 Assent Assent Assent Assent
61 0.27 0.10 0.03 0.52 Assent Assent Assent Assent
62 0.09 0.05 0.16 0.06 Assent Assent Assent Assent
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where the intake of ethyl alcohol cannot be clearly 
traced solely by correspondence with the EtG datum 
detected in the biological fluids being examined, it is 
important to evaluate not only ethanol but also other 
parameters that could provide further indications on 
the source of the alcohol found, such as n-propanol 
and acetaldehyde, which in high concentrations can 
be a good indication of suspected putrefaction [29, 
30].
In conclusion, our study has clearly confirmed the 
possibility of using VH to determine EtG following the 
intake of ethyl alcohol. In particular, it can be said that 
the EtG detected in this matrix, in real cases taken from 
corpses at different degrees of preservation, proved to 
be an excellent parameter for differentiating between 
ante-mortem intake of ethanol and post-mortem forma-
tion due to putrefactive phenomena.
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Figure 1
Samples results: comparison of distribution of the ethanol in blood (g/L) and EtG-VH (mg/L) concentration in 63 cases.
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Figure 2 
Samples results: comparison of ethanol in blood (g/L) and EtG-VH (mg/L) ratio with ethanol in blood (g/L) and EtG-blood (mg/L) 
in 34 cases. 
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